NCT00599274 - Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis | Biotech Hunter

Enrollment

136

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

May 31, 2003

Conditions

Multiple Sclerosis

Interventions

DRUG

Interferon beta-1a

injection once a week

DRUG

Interferon beta-1a

injection three times a week

Trial Locations (11)

Research Site, Los Angeles

Research Site, Walnut Creek

Research Site, Shreveport

Research Site, Worcester

Research Site, Charlotte

Research Site, Columbus

Research Site, Edmonds

Research Site, Milwaukee

Coordinating Research Site, Woodville

Coordinating Research Site, Linz

Coordinating Research Site, Halifax